Lehang Lin

Guangdong Provincial Key Laboratory Of Malignant Tumor Epigenetics And Gene Regulation
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Correction: Pan-cancer oncogenic properties and therapeutic potential of SF3B4.

Correction: Pan-cancer oncogenic properties and therapeutic potential of SF3B4.

Journal: Cancer gene therapy
Published: January 21, 2026

Identifying metabolism-related genes in liver cancer through weighted gene co-expression network analysis and machine learning.

Identifying metabolism-related genes in liver cancer through weighted gene co-expression network analysis and machine learning.

Journal: Frontiers in genetics
Published: June 26, 2025

MRI-Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy.

MRI-Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy.

Journal: Cancer medicine
Published: June 16, 2025

Pan-cancer oncogenic properties and therapeutic potential of SF3B4.

Pan-cancer oncogenic properties and therapeutic potential of SF3B4.

Journal: Cancer gene therapy
Published: July 04, 2024

The SETDB1-PC4-UPF1 post-transcriptional machinery controls periodic degradation of CENPF mRNA and maintains mitotic progression.

The SETDB1-PC4-UPF1 post-transcriptional machinery controls periodic degradation of CENPF mRNA and maintains mitotic progression.

Journal: Cell death and differentiation
Published: June 24, 2024

CYR61 Acts as an Intracellular Microtubule-Associated Protein and Coordinates Mitotic Progression via PLK1-FBW7 Pathway.

CYR61 Acts as an Intracellular Microtubule-Associated Protein and Coordinates Mitotic Progression via PLK1-FBW7 Pathway.

Journal: International journal of biological sciences
Published: December 18, 2023

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Journal: Cell death & disease
Published: August 17, 2021

RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma.

RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma.

Journal: Molecular therapy. Nucleic acids
Published: July 07, 2021

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Journal: Cell death & disease
Published: September 29, 2020

Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.

Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.

Journal: Nucleic acids research
Published: September 21, 2020

CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.

CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.

Journal: American journal of cancer research
Published: August 15, 2020

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications.

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications.

Journal: Frontiers in oncology
Published: April 07, 2020
Showing 1-12 of 21

Last Updated: 09/26/2026